ZyVersa Therapeutics (ZVSA) Enterprise Value (2022 - 2026)
ZyVersa Therapeutics' Enterprise Value was $1.32 million in Q1 2026, up 280.7% from $345,833 a year earlier and up 95.5% from the prior quarter.
Powered by 
Analysis
ZyVersa Therapeutics (ZVSA) Enterprise Value (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, ZyVersa Therapeutics' Enterprise Value was $614,668 through Mar 31, 2026; for FY2025, it came in at $673,535.
- Enterprise Value shows a three-year compound annual growth rate of -89.3% (FY2022 to FY2025).
- In earlier years, Enterprise Value was -$354,289 in FY2024, -$2.26 million in FY2023 and $543.64 million in FY2022.
- Quarterly Enterprise Value has moved between -$2.26 million (Q4 2023) and $79.96 million (Q2 2022) over five years.
- Compared with a year earlier, Enterprise Value was higher in two of the last six quarters, with growth averaging 15.8%.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2026 (growth of 280.7%); the worst was Q2 2023 (a decline of 94.8%).
- Per Business Quant data, ZVSA's Enterprise Value in the three quarters before Q1 2026 was $673,535 (Q4 2025), $686,410 (Q3 2025) and $3.2 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn |
| 10 | ZyVersa Therapeutics | 404,796.06 | -599,719.94 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | 673,534.56 |
| Sep 30, 2025 | 686,410.20 |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 345,832.63 |
| Dec 31, 2024 | -354,289.08 |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 3.02 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Dec 31, 2023 | -2.26 Mn |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 4.16 Mn |
| Mar 31, 2023 | 16.34 Mn |
| Dec 31, 2022 | 8.25 Mn |
| Jun 30, 2022 | 79.96 Mn |
| Mar 31, 2022 | 79.64 Mn |
API Access
ZyVersa Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ZVSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ZVSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ZVSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();